Kukje Pharma Co., Ltd. (KRX:002720)
4,495.00
+600.00 (15.40%)
At close: Oct 13, 2026
| Market Cap | 91.53B +2.6% |
| Revenue (ttm) | 181.27B +8.0% |
| Net Income | 5.00B -21.5% |
| EPS | 239.91 -23.6% |
| Shares Out | 20.36M |
| PE Ratio | 16.24 |
| Forward PE | n/a |
| Dividend | 30.00 (0.67%) |
| Ex-Dividend Date | Mar 12, 2026 |
| Volume | 31,939,997 |
| Open | 3,730.00 |
| Previous Close | 3,895.00 |
| Day's Range | 3,650.00 - 4,850.00 |
| 52-Week Range | 2,810.00 - 5,470.00 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |